Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial

BACKGROUND: The ProPrems trial, a multi-center, double-blind, placebo-controlled randomized trial, previously reported a 54% reduction in necrotizing enterocolitis (NEC) of Bell stage 2 or more from 4.4 to 2.0% in 1099 infants born before 32 completed weeks’ gestation and weighing < 1500 g, recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Plummer, Erica L., Bulach, Dieter M., Murray, Gerald L., Jacobs, Susan E., Tabrizi, Sepehr N., Garland, Suzanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234596/
https://www.ncbi.nlm.nih.gov/pubmed/30424728
http://dx.doi.org/10.1186/s12866-018-1326-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234596/
https://www.ncbi.nlm.nih.gov/pubmed/30424728
http://dx.doi.org/10.1186/s12866-018-1326-1

Ejemplares similares